Valuation : Ind-Swift Laboratories Limited

Market Cap 11.4B 119M 103M 97.32M 88.21M 165M 166M 1.16B 444M 5.8B 448M 438M 18.32B P/E 2024
1.41x
P/E 2025 2.38x
Enterprise Value 7.13B 74.64M 64.31M 60.9M 55.2M 104M 104M 723M 278M 3.63B 280M 274M 11.46B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
36.27%
Yield 2024 *
-
Yield 2025 -
1 day+2.08%
1 week+3.39%
Current month+5.61%
1 month+62.43%
3 months+136.61%
6 months+170.17%
Current year+337.15%
1 week 351
Extreme 351
404
1 month 284.84
Extreme 284.84
404
Current year 87.25
Extreme 87.25
404
1 year 87.15
Extreme 87.15
404
3 years 68.72
Extreme 68.72
404
5 years 52.65
Extreme 52.65
404
10 years 15
Extreme 15
404
Manager TitleAgeSince
Chief Executive Officer 74 04/01/1995
Chief Executive Officer 44 15/06/2011
Director of Finance/CFO - 29/09/2018
Director TitleAgeSince
Director/Board Member 44 -
Chairman 74 -
Director/Board Member 35 23/03/2010
Date Insider Type Main position Quantity % Market Cap. Importance
12/09/24 Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+2.08%+3.39%+249.78%+315.92% 343M
-1.13%-3.97%+15.48%+62.77% 46.7B
-1.13%-7.39%+36.30%+109.40% 39.11B
+0.12%-2.09%+7.65%+78.16% 11.66B
-0.53%-2.06%-12.65%+9.75% 11.6B
-0.38%0.00%+19.82%+136.36% 9.19B
+0.32%-2.19%+24.68%+33.37% 7.27B
+0.17%-1.62%+13.53%+211.41% 7.13B
-1.00%-6.83%+33.22%-17.14% 7.15B
-3.13%-4.45%-45.09%+17.23% 5.13B
Average -0.49%-2.66%+34.27%+95.72% 14.53B
Weighted average by Cap. -0.87%-3.61%+18.14%+77.86%

Financials

2024 2025
Net sales 12.97B 136M 117M 111M 100M 188M 189M 1.32B 506M 6.6B 510M 499M 20.86B 5.62B 58.8M 50.66M 47.97M 43.48M 81.57M 81.98M 570M 219M 2.86B 221M 216M 9.03B
Net income 4.21B 44.06M 37.97M 35.95M 32.58M 61.13M 61.44M 427M 164M 2.14B 165M 162M 6.77B 2.5B 26.22M 22.59M 21.39M 19.39M 36.37M 36.56M 254M 97.69M 1.27B 98.47M 96.3M 4.03B
Net Debt -4.15B -43.47M -37.45M -35.46M -32.15M -60.31M -60.61M -421M -162M -2.11B -163M -160M -6.68B -4.27B -44.65M -38.47M -36.42M -33.02M -61.94M -62.25M -433M -166M -2.17B -168M -164M -6.86B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
11/09/26 385.35 +2.08% 565,658
10/09/26 ₹377.50 -2.84% 372,420
09/09/26 ₹388.55 +0.06% 704,593
08/09/26 ₹388.30 +5.32% 2,095,086
07/09/26 ₹368.70 +3.58% 650,855
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!